KEGG   PATHWAY: tmu05213
Entry
tmu05213                    Pathway                                
Name
Endometrial cancer - Trichechus manatus latirostris (Florida manatee)
Description
Endometrial cancer (EC) is the most common gynaecological malignancy and the fourth most common malignancy in women in the developed world after breast, colorectal and lung cancer. Two types of endometrial carcinoma are distinguished with respect to biology and clinical course. Type-I carcinoma is related to hyperestrogenism by association with endometrial hyperplasia, frequent expression of estrogen and progesterone receptors and younger age, whereas type-II carcinoma is unrelated to estrogen, associated with atrophic endometrium, frequent lack of estrogen and progesterone receptors and older age. The morphologic differences in these cancers are mirrored in their molecular genetic profile with type I showing defects in DNA-mismatch repair and mutations in PTEN, K-ras, and beta-catenin, and type II showing aneuploidy, p53 mutations, and her2/neu amplification.
Class
Human Diseases; Cancer: specific types
Pathway map
tmu05213  Endometrial cancer
tmu05213

Organism
Trichechus manatus latirostris (Florida manatee) [GN:tmu]
Gene
101355971  pro-epidermal growth factor [KO:K04357]
101356822  epidermal growth factor receptor isoform X1 [KO:K04361] [EC:2.7.10.1]
101358678  phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
101346849  phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
101359658  phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X2 [KO:K00922] [EC:2.7.1.153]
101351035  phosphatidylinositol 3-kinase regulatory subunit gamma [KO:K02649]
101343804  phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
101347746  phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
101355243  phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X1 [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
101353040  3-phosphoinositide-dependent protein kinase 1 [KO:K06276] [EC:2.7.11.1]
101346618  integrin-linked protein kinase [KO:K06272] [EC:2.7.11.1]
101360493  RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
101356099  RAC-beta serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
101350197  RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
101355103  caspase-9 [KO:K04399] [EC:3.4.22.62]
101352047  bcl2-associated agonist of cell death [KO:K02158]
101354741  forkhead box protein O3 [KO:K09408]
101359012  growth factor receptor-bound protein 2 [KO:K04364]
101359592  son of sevenless homolog 1 isoform X1 [KO:K03099]
101347392  son of sevenless homolog 2 isoform X1 [KO:K03099]
101342804  GTPase HRas isoform X2 [KO:K02833]
101347525  GTPase KRas isoform X3 [KO:K07827]
101344230  GTPase NRas isoform X1 [KO:K07828]
101351589  serine/threonine-protein kinase A-Raf [KO:K08845] [EC:2.7.11.1]
101353421  serine/threonine-protein kinase B-raf [KO:K04365] [EC:2.7.11.1]
101357840  RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
101343332  dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
101341078  dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
101340589  mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
101358526  mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
101352015  ETS domain-containing protein Elk-1 [KO:K04375]
101347000  DNA mismatch repair protein Mlh1 [KO:K08734]
101350182  cadherin-1 isoform X2 [KO:K05689]
101351897  catenin beta-1 [KO:K02105]
101360973  catenin alpha-2 isoform X4 [KO:K05691]
101361370  catenin alpha-1 isoform X2 [KO:K05691]
101343640  catenin alpha-3 [KO:K05691]
101346985  axin-1 isoform X2 [KO:K02157]
101347495  axin-2 [KO:K04385]
101346660  adenomatous polyposis coli protein 2 [KO:K02085]
101341158  adenomatous polyposis coli protein isoform X1 [KO:K02085]
101349186  glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
101350837  LOW QUALITY PROTEIN: transcription factor 7 [KO:K02620]
101341696  transcription factor 7-like 1 [KO:K04490]
101345532  transcription factor 7-like 2 isoform X1 [KO:K04491]
101345125  lymphoid enhancer-binding factor 1 isoform X2 [KO:K04492]
101349786  myc proto-oncogene protein [KO:K04377]
101359745  G1/S-specific cyclin-D1 [KO:K04503]
101351852  cellular tumor antigen p53 [KO:K04451]
101342008  cyclin-dependent kinase inhibitor 1 isoform X2 [KO:K06625]
101353013  growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
101361119  growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
101348099  growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
101356564  apoptosis regulator BAX [KO:K02159]
101341201  bcl-2 homologous antagonist/killer [KO:K14021]
101349998  DNA damage-binding protein 2 [KO:K10140]
101359617  DNA polymerase kappa isoform X1 [KO:K03511] [EC:2.7.7.7]
101354844  receptor tyrosine-protein kinase erbB-2 isoform X1 [KO:K05083] [EC:2.7.10.1]
Compound
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Ryan AJ, Susil B, Jobling TW, Oehler MK.
  Title
Endometrial cancer.
  Journal
Cell Tissue Res 322:53-61 (2005)
DOI:10.1007/s00441-005-1109-5
Reference
  Authors
Lax SF.
  Title
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  Journal
Virchows Arch 444:213-23 (2004)
DOI:10.1007/s00428-003-0947-3
Reference
  Authors
Shiozawa T, Konishi I.
  Title
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  Journal
Int J Clin Oncol 11:13-21 (2006)
DOI:10.1007/s10147-005-0546-1
Reference
  Authors
Hecht JL, Mutter GL.
  Title
Molecular and pathologic aspects of endometrial carcinogenesis.
  Journal
J Clin Oncol 24:4783-91 (2006)
DOI:10.1200/JCO.2006.06.7173
Reference
  Authors
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  Title
Molecular pathology of endometrial hyperplasia and carcinoma.
  Journal
Hum Pathol 32:569-77 (2001)
DOI:10.1053/hupa.2001.25929
Reference
  Authors
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  Title
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  Journal
J Clin Oncol 22:3126-32 (2004)
DOI:10.1200/JCO.2004.11.154
Reference
PMID:7585656
  Authors
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  Title
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  Journal
Cancer Res 55:5693-8 (1995)
Reference
  Authors
Kim D, Chung J.
  Title
Akt: versatile mediator of cell survival and beyond.
  Journal
J Biochem Mol Biol 35:106-15 (2002)
DOI:10.5483/bmbrep.2002.35.1.106
Related
pathway
tmu04010  MAPK signaling pathway
tmu04012  ErbB signaling pathway
tmu04060  Cytokine-cytokine receptor interaction
tmu04110  Cell cycle
tmu04115  p53 signaling pathway
tmu04151  PI3K-Akt signaling pathway
tmu04310  Wnt signaling pathway
tmu04520  Adherens junction
KO pathway
ko05213   
LinkDB

DBGET integrated database retrieval system